Trials in Follow Up

• A5288: MULTIOCTAVE, Management Using the Latest Technologies in...

  Study Location: India

  Eligibility: HIV-1-infected males and females at non-US sites, aged ≥18 years, who have experience with or resistance to NRTIs, NNRTIs,...

  Enrollment: Closed

  Read More

• A5302:  BioBank for Surrogate Marker Research for TB (B-SMART)

  Study Location: India

  Eligibility:

  Enrollment: Closed

  Read More

• A5320: Viral Hepatitis C Infection Long-term Cohort Study (V-HICS)

  Study Location: Baltimore

  Eligibility: Men and women ≥ 18 years old, HCV/HIV-1 coinfected who failed HCV therapy any time after HCV/DAA treatment discontinuation...

  Enrollment: Closed

  Read More

• A5322: Long-Term Follow-up of Older HIV-infected Adults in the ACTG:...

  Study Location: Baltimore

  Eligibility: Participants actively followed in the ALLRT (A5001) at the time of enrollment into A5322 or completed follow-up in ALLRT (A5001)...

  Enrollment: Closed

  Read More

• A5329: Interferon –Free Therapy for Chronic Hepatitis C Virus Genotype 1...

  Study Location: Baltimore

  Eligibility: HIV and Hepatitis C co-infected people 18 to 70 years old HIV viral load less than 50 copies Currently on one of the...

  Enrollment: Closed

  Read More

• A5332: Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)

  Study Location: BaltimoreIndia

  Eligibility: HIV infected men and women between the ages of 40 and 75 On HIV medications for at least 6 months CD4 cell count greater...

  Enrollment: Closed

  Read More

• A5349: Rifapentine-containing treatment shortening regimens for pulmonary...

  Study Location: India

  Eligibility: Ages Eligible for Study: 12 Years and older   (Child, Adult, Senior) Genders Eligible for Study:   Both Accepts...

  Enrollment: Closed

  Read More

• A5350: Effects of Visbiome Extra Strength on Gut Microbiome and Immune...

  Study Location:

  Eligibility: Participants in the study must: Have HIV infection Be on stable HIV treatment for at least the last 24 weeks Have...

  Enrollment: Closed

  Read More

• A5361s: Pitavastatin to REduce Physical Function Impairment and FRailty in...

  Study Location: Baltimore

  Eligibility: HIV infected men and women between the ages of 40 and 75 Co-enrolled in REPRIEVE and the Mechanistic (CT) substudy Taking...

  Enrollment: Closed

  Read More

• HPTN 078: Enhancing Recruitment, Linkage to Care and Treatment for...

  Study Location: Baltimore

  Eligibility: Ages Eligible for Study:   16 Years and older Genders Eligible for Study:   Male Accepts Healthy Volunteers:  ...

  Enrollment: Closed

  Read More

• HPTN083: A Phase 2b/3 Double Blind Safety and Efficacy Study of Injectable...

  Study Location: Baltimore

  Eligibility: HPTN 083 will enroll approximately 4500 HIV-uninfected MSM and TGW at risk for acquiring HIV infection, ages 18 or older at...

  Enrollment: Closed

  Read More

• NWCS 408: Examining Longitudinal Cytokine Profiles in HIV-TB Co-infected...

  Study Location: India

  Eligibility:

  Enrollment: Closed

  Read More

• NWCS 414, Evaluation of a Serum Biosignature for Identifying HIV-infected...

  Study Location: India

  Eligibility: N/A

  Enrollment: Closed

  Read More

• NWCS 445: Novel Biomarkers to Shorten TB Treatment

  Study Location: India

  Eligibility: Partncipants enrolled in “Rifapentine-containing treatment shortening regimens for pulmonary tuberculosis: a randomized,...

  Enrollment: Closed

  Read More

• P2010: Phase III Study of the Virologic Efficacy and Safety of...

  Study Location: India

  Eligibility: HIV-1-infected pregnant women initiating antiretroviral therapy at 14-28 weeks gestation, and their infants

  Enrollment: Closed

  Read More